Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome-Reference-Cited by-同舟云学术

Randomised clinical trial: the clinical effects of a novel neurokinin receptor antagonist, DNK333, in women with diarrhoea-predominant irritable bowel syndrome

Published:2011-04-20 Issue:12 Volume:33 Page:1311-1321
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:

Author:

Zakko S.,Barton G.,Weber E.,Dunger-Baldauf C.,Rühl A.

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2011.04656.x/fullpdf

Reference34 articles.

1. A comparative reappraisal of the Rome II and Rome III diagnostic criteria: are we getting closer to the ‘true’ prevalence of irritable bowel syndrome?;Sperber;Eur J Gastroenterol Hepatol,2007

2. Prevalence, sociodemography, and quality of life of older versus younger patients with irritable bowel syndrome: a population-based study;Minocha;Dig Dis Sci,2006

3. Irritable bowel syndrome in the United States: symptom patterns and impact;Hungin;Aliment Pharmacol Ther,2005

4. The epidemiology of irritable bowel syndrome in North America: a systematic review;Saito;Am J Gastroenterol,2002

5. Quality of life in managed care patients with irritable bowel syndrome;Wilson;Manag Care Interface,2004

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antagonism of Tachykinin receptor 1 promotes Foxp3+ regulatory CD4 T cells and controls gut mucosal inflammation;2024-03-28

2. Update on treatment of abdominal pain in irritable bowel syndrome: A narrative review;Pharmacology & Therapeutics;2023-05

3. Nocebo response intensity and influencing factors in the randomized clinical trials of irritable bowel syndrome: A systematic review and meta-analysis;Frontiers in Medicine;2022-12-20

4. Targeting the endocannabinoid system for the treatment of abdominal pain in irritable bowel syndrome;Nature Reviews Gastroenterology & Hepatology;2022-09-27

5. Neurokinin receptors and their implications in various autoimmune diseases;Current Research in Immunology;2021